Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62–70.
48.
Harlow BL, Wise LA, Otto MW, et al. Depression and its inﬂuence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2003;60:29–36.
49.
Soares CN, Cohen LS, Otto MW, et al. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med 2001;10:873–878.
50.
Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004;161:2238–2244.
51.
Oinonen KA, Mazmanian D. To what extent do oral contraceptives inﬂuence mood and affect? J Affect Disord 2002;70:229–240.
52.
Endicott J, Amsterdam J, Eriksson E, et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999;8:663–679.
53.
Halbreich U, Borenstein J, Pearlstein T, et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;28:1023–1030.
54.
Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2003;28:25–37.
55.
Hamilton JA, Parry BL, Blumenthal SL. The menstrual cycle in context: I. Affective syndromes associated with reproductive hormonal changes. J Clin Psych 1988;49:474–480.
56.
Jensvold MF. Psychiatric aspects of the menstrual cycle. In: Stewart DE, Stotland NL, eds. Psychological aspects of women’s health care. Washington, DC: American Psychiatric Press, 1993:165–192.
57.
Bailey JW, Cohen LS. Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome. J Womens Health Gend Based Med 1999;8:1181–1184.
58.
Brand B. Trauma and women. Psychiatr Clin North Am 2003;26: 759–779.
59.
Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 2003;28:39–53.
60.
Canning S, Waterman M, Orsi N, et al. The efficacy of Hypericum perforatum (St. John’s wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs 2010;24:207–225 61.